ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Galapagos

Galapagos (GLPG)

416.00
0.00
( 0.00% )
Updated: 20:00:00

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
416.00
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
416.00
Open
-
Last Trade
(O)
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

GLPG Latest News

Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024

Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024 Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ:...

Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications

Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and...

Galapagos creates new subscription right plans

Galapagos creates new subscription right plans Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of...

Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.

Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S. BCA's national network of blood centers...

Galapagos reports first quarter 2024 financial results  

Galapagos reports first quarter 2024 financial results   Advanced potentially best-in-class cell therapy and small molecule R&D pipeline comprising four clinical assets and >15...

Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024

Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024 Mechelen, Belgium; 30 April 2024, 22:01 CET;...

Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024

Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 Two oral presentations and one poster on encore...

Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings

Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings Publication of annual report for financial year 2023Annual Shareholders’ Meeting...

Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board

Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board Mechelen, Belgium; 26 March 2024, 21:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today...

Galapagos announces full year 2023 results and outlook for 2024

Galapagos announces full year 2023 results and outlook for 2024 Full year 2023 key financials: Group net revenues of €783.5 million, including Jyseleca® net sales of €112.3 million Cash and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NMHINatures Miracle Holding Inc
$ 0.9935
(183.86%)
5.41M
GPGreenPower Motor Company Inc
$ 1.79
(59.11%)
4
FEIMFrequency Electronics Inc
$ 13.30
(31.68%)
40.96k
LGHLWLion Group Holding Ltd
$ 0.0093
(30.99%)
156
ENGENGlobal Corp
$ 2.22
(29.82%)
258
RNAZTransCode Therapeutics Inc
$ 0.3395
(-57.16%)
263.82k
MIRAMIRA Pharmaceuticals Inc
$ 3.69
(-26.35%)
659.83k
NUKKNukkleus Inc
$ 0.3892
(-21.85%)
116.87k
CMAXCareMax Inc
$ 4.08
(-21.39%)
159.5k
XCURExicure Inc
$ 0.4119
(-17.59%)
5.36k
NMHINatures Miracle Holding Inc
$ 0.9935
(183.86%)
5.41M
LIFWMSP Recovery Inc
$ 0.6287
(24.08%)
2.68M
BREABrera Holdings PLC
$ 0.6661
(-9.63%)
1.53M
SLNASelina Hospitality PLC
$ 0.0347
(-6.22%)
964.09k
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 14.41
(0.84%)
795.85k

Discussion

View Full Feed
RealDutch RealDutch 4 minutes ago
It does raise some questions. But...

The current purchase price is based on a cycle rate of 15 days. So every 15 days you will generate some profit and this will double over a 5-year period.
This is SWIM. (Systematic Wealth and Income Multiplier). Which we also have for Rice a
SIRI
floridaboy floridaboy 6 minutes ago
Ugly session yesterday, impatience continues to grow...
SAPX
LVerstee LVerstee 8 minutes ago
The buy back price?
ITUP
Handlamera Handlamera 11 minutes ago
I guess that the market will set the price and define the spread? That’s why the marketplace is set up?
ITUP
Edward Edward 12 minutes ago
LOL!!! How can anyone interpret my message as “being so upset”
Somehow your ability to read and comprehend has not improved in your time here.

So funny, so upset over a stock that is selling for .0016. LMAO.
VXIT
twiztedtriple6 twiztedtriple6 15 minutes ago
Probably so. It's the same thing that he did while he was CEO of BRNE.
BRNE
Investor2014 Investor2014 16 minutes ago
The SEC definition is at odds with clinical trial outcome statistics.

“Trial success is not material because that is the presumed outcome. Most companies would PR a trial success since that is a positive piece of news.”

If the SEC was right about their definition it wou
AVXL
Number sleven Number sleven 24 minutes ago
Nuke, Yes.
Sleven,
AMRN
glenn1919 glenn1919 25 minutes ago
TC......PSNY....GOEV......MULN.......https://stockcharts.com/h-sc/ui?s=TC&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=PSNY&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=GOEV&p=W&b=5&g=0&id=p843540149361
https://stockcharts.com/h-sc/ui?s=MULN&p=W
GOEV MULN PSNY
B_B! B_B! 27 minutes ago
Small-Cap Rotation or Death Sentence for Hedge Funds? It’s Too Early to Tell.
Investors should pay close attention to the behavior between small-cap and large-cap stocks
12h ago • By Michael A. Gayed

The stock market is dangerous right now and all investors are playing
NVDA
LVerstee LVerstee 27 minutes ago
"(a) our Sell price will be -> (Current Spot Ask Oz/480)*1.01 + 1.45"

1.01 markup plus an additional 1.45. This means buyers are paying more than the spot price plus a significant additional fee.

Why would a buyer go for that?
ITUP
B_B! B_B! 34 minutes ago
AMC has restructured its debt, I hope Amazon will make a move soon.
Amazon is still expanding its film business.

Amazon Prime Video acquires the iconic Bray Film Studios in the UK
July 22, 2024

The legendary Bray Film Studios will be the new production ho
AMC
stock1ace1 stock1ace1 37 minutes ago
Brea .74
Tom turtles Tom turtles 38 minutes ago
This is one crazy stock
SYTA
Monksdream Monksdream 38 minutes ago
Bloomberg reported that $81 million, a one-day record amount was raised for the Democrats
Certainly an expression of confidence in Harris
ShadowDiviner72 ShadowDiviner72 40 minutes ago
Finally, we arrived to the day we have been waiting for since November 2023. I want to highlight 1 fact:
"Since all patient data will be included in the final locked database, we will remain blinded and will announce the comprehensive results of the full trial, including Stage II results, ra
JAGX
Bull_Dolphin Bull_Dolphin 42 minutes ago
More on the narrative unravelling:

https://revolver.news/2024/07/entire-trump-assassination-plot-about-to-blow-thanks-to-mysterious-atf-agent-just-went-dark/
stock1ace1 stock1ace1 43 minutes ago
Brea .69
ddls ddls 43 minutes ago
Looks like you're still PRETENDING.
BIEL
Here Today Here Today 43 minutes ago
“The Company intends to use the net proceeds from the offering primarily for product development activities, including one or more clinical trials with TTX-MC138, its lead therapeutic candidate, and related investigational new drug (IND) enabling studies, and for working capital and other general co
RNAZ
Here Today Here Today 45 minutes ago
Just sucks that they priced the offering at $.30 a share for 10 million shares. They need the trial to start ASAP.
RNAZ
LVerstee LVerstee 45 minutes ago
To clarify your statement:

According to your message, the current selling price is $8.88 per TOKEN, while the buyback price is only $4.93. This results in a substantial spread of $3.95 per TOKEN, favoring the company.

This significant discrepancy suggests that the TOKEN
ITUP
Here Today Here Today 46 minutes ago
Time to munch on the cheapies!!!!
RNAZ
glenn1919 glenn1919 49 minutes ago
TC.....................................https://stockcharts.com/h-sc/ui?s=TC&p=W&b=5&g=0&id=p84354014936